|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0004096,
umls-concept:C0004906,
umls-concept:C0117996,
umls-concept:C0205081,
umls-concept:C0205082,
umls-concept:C0332154,
umls-concept:C0439234,
umls-concept:C1257890,
umls-concept:C1512888,
umls-concept:C1707455,
umls-concept:C2603343
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1993-11-8
|
|
pubmed:abstractText |
High dose inhaled glucocorticosteroids are increasingly used in the management of patients with moderate to severe asthma. Although effective, they may cause systemic side effects. Fluticasone propionate is a topically active inhaled glucocorticosteroid which has few systemic effects at high doses.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-1426211,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-1496495,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-1775677,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-2287791,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-2287792,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-3512282,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-3547757,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-3893509,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-6130294,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-7037035,
http://linkedlifedata.com/resource/pubmed/commentcorrection/8211872-8202917
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0040-6376
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
817-23
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8211872-Administration, Topical,
pubmed-meshheading:8211872-Adolescent,
pubmed-meshheading:8211872-Adult,
pubmed-meshheading:8211872-Aged,
pubmed-meshheading:8211872-Aged, 80 and over,
pubmed-meshheading:8211872-Androstadienes,
pubmed-meshheading:8211872-Anti-Inflammatory Agents,
pubmed-meshheading:8211872-Asthma,
pubmed-meshheading:8211872-Beclomethasone,
pubmed-meshheading:8211872-Double-Blind Method,
pubmed-meshheading:8211872-Female,
pubmed-meshheading:8211872-Humans,
pubmed-meshheading:8211872-Hydrocortisone,
pubmed-meshheading:8211872-Lung,
pubmed-meshheading:8211872-Male,
pubmed-meshheading:8211872-Middle Aged,
pubmed-meshheading:8211872-Peak Expiratory Flow Rate
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group.
|
|
pubmed:affiliation |
Instituto di Mallattie, Infettive e dell'Apparato Respiratorio, Università di Ferrara, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
